196 related articles for article (PubMed ID: 34058766)
1. Altered Fibrinolysis in Hematological Malignances.
Bønløkke ST; Ommen HB; Hvas AM
Semin Thromb Hemost; 2021 Jul; 47(5):569-580. PubMed ID: 34058766
[TBL] [Abstract][Full Text] [Related]
2. Impaired fibrinolysis and increased clot strength are potential risk factors for thrombosis in lymphoma.
Bønløkke ST; Fenger-Eriksen C; Ommen HB; Hvas AM
Blood Adv; 2023 Nov; 7(22):7056-7066. PubMed ID: 37756519
[TBL] [Abstract][Full Text] [Related]
3. Intravascular clotting activation and bleeding in patients with hematologic malignancies.
Tallman MS; Kwaan HC
Rev Clin Exp Hematol; 2004 Jun; 8(1):E1. PubMed ID: 16029967
[TBL] [Abstract][Full Text] [Related]
4. Disordered hemostasis associated with severely depressed fibrinolysis demonstrated using a simultaneous thrombin and plasmin generation assay during L-asparaginase induction therapy in pediatric acute lymphoblastic leukemia.
Ishihara T; Nogami K; Ochi S; Ishida T; Kosaka Y; Sawada A; Inoue M; Osone S; Imamura T; Hosoi H; Shima M
Pediatr Blood Cancer; 2020 Jan; 67(1):e28016. PubMed ID: 31556233
[TBL] [Abstract][Full Text] [Related]
5. Disseminated intravascular coagulation in children with cancer: A systematic review.
Kongstad C; Mikkelsen TS; Hvas AM
Pediatr Hematol Oncol; 2020 Aug; 37(5):390-411. PubMed ID: 32202958
[TBL] [Abstract][Full Text] [Related]
6. L-Asparaginase and the effect of age on coagulation and fibrinolysis in childhood acute lymphoblastic leukemia.
Appel IM; Hop WC; van Kessel-Bakvis C; Stigter R; Pieters R
Thromb Haemost; 2008 Aug; 100(2):330-7. PubMed ID: 18690355
[TBL] [Abstract][Full Text] [Related]
7. [Thrombosis and DIC in hematological malignancies].
Asakura H
Rinsho Ketsueki; 2014 Oct; 55(10):2066-75. PubMed ID: 25297773
[No Abstract] [Full Text] [Related]
8. Altered Fibrinolysis during and after Surgery.
Colomina MJ; Méndez E; Sabate A
Semin Thromb Hemost; 2021 Jul; 47(5):512-519. PubMed ID: 33878781
[TBL] [Abstract][Full Text] [Related]
9. Systemic AL amyloidosis with disseminated intravascular coagulation associated with hyperfibrinolysis.
Takahashi T; Suzukawa M; Akiyama M; Hatao K; Nakamura Y
Int J Hematol; 2008 May; 87(4):371-374. PubMed ID: 18398581
[TBL] [Abstract][Full Text] [Related]
10. Management of Thrombohemorrhagic Syndromes (THS) in hematologic malignancies.
Falanga A; Rickles FR
Hematology Am Soc Hematol Educ Program; 2007; ():165-71. PubMed ID: 18024625
[TBL] [Abstract][Full Text] [Related]
11. Coagulation and fibrinolytic features in AL amyloidosis with abnormal bleeding and usefulness of tranexamic acid.
Arahata M; Takamatsu H; Morishita E; Kadohira Y; Yamada S; Ichinose A; Asakura H
Int J Hematol; 2020 Apr; 111(4):550-558. PubMed ID: 31897889
[TBL] [Abstract][Full Text] [Related]
12. Fibrinolysis Shutdown Is Associated With Thrombotic and Hemorrhagic Complications and Poorer Outcomes After Liver Transplantation.
Nicolau-Raducu R; Beduschi T; Vianna R; Diez C; Sleem M; Singh BP; Vasileiou G; Raveh Y
Liver Transpl; 2019 Mar; 25(3):380-387. PubMed ID: 30548128
[TBL] [Abstract][Full Text] [Related]
13. Bleeding in acute promyelocytic leukemia (APL): fibrinolysis or defibrination?
Krsnik I; Escribá A; López-Rubio M; Alarcón C; del Potro E; Díaz-Mediavilla J
Nouv Rev Fr Hematol (1978); 1991; 33(1):39-41. PubMed ID: 1945823
[TBL] [Abstract][Full Text] [Related]
14. Changes in hemostatic and fibrinolytic proteins in patients receiving L-asparaginase therapy.
Saito M; Asakura H; Jokaji H; Uotani C; Kumabashiri I; Ito K; Matsuda T
Am J Hematol; 1989 Sep; 32(1):20-3. PubMed ID: 2757000
[TBL] [Abstract][Full Text] [Related]
15. A new assay for global fibrinolysis capacity (GFC): Investigating a critical system regulating hemostasis and thrombosis and other extravascular functions.
Amiral J; Laroche M; Seghatchian J
Transfus Apher Sci; 2018 Feb; 57(1):118-126. PubMed ID: 29525568
[TBL] [Abstract][Full Text] [Related]
16. Thrombosis and hemostatic abnormalities in hematological malignancies.
Colombo R; Gallipoli P; Castelli R
Clin Lymphoma Myeloma Leuk; 2014 Dec; 14(6):441-50. PubMed ID: 25018062
[TBL] [Abstract][Full Text] [Related]
17. Cerebrovascular complications in cancer patients.
Rogers LR
Neurol Clin; 2003 Feb; 21(1):167-92. PubMed ID: 12690649
[TBL] [Abstract][Full Text] [Related]
18. Decreased Plasma Fibrinolytic Potential As a Risk for Venous and Arterial Thrombosis.
Lisman T
Semin Thromb Hemost; 2017 Mar; 43(2):178-184. PubMed ID: 27472427
[TBL] [Abstract][Full Text] [Related]
19. Addition of Arsenic Trioxide into Induction Regimens Could Not Accelerate Recovery of Abnormality of Coagulation and Fibrinolysis in Patients with Acute Promyelocytic Leukemia.
Zhang Y; Wu S; Luo D; Zhou J; Li D
PLoS One; 2016; 11(1):e0147545. PubMed ID: 26812490
[TBL] [Abstract][Full Text] [Related]
20. Clinical disorders of fibrinolysis: a critical review.
Francis RB
Blut; 1989 Jul; 59(1):1-14. PubMed ID: 2526671
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
